drugset / Trial / NCT03316170
Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors
RandomizedParallel-groupOpen-labelSupportive care
Summary
The objectives of this pilot clinical trial are: 1) To evaluate the feasibility and acceptability of a new approach to smoking cessation induction treatment in cancer survivors with low social resources, and 2) To assess the effectiveness of said treatment for key events in the process of smoking cessation.
Timeline
- Start
- 2017-11-06
- Primary completion
- 2020-03-31
- Completion
- 2020-03-31
Outcome
Missed primary endpoint
registry analysis (superiority test); Social Support + NRT Sampling vs Social Support; p = .06; Mean Difference (Final Values) -0.86 (95% CI -1.75 to 0.30); t-test, 2 sided NCT03316170 ↗
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotine | Unknown | — | — |
Indications
No indication recorded.